Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Net Cash Flow: 2016-2024

Historic Net Cash Flow for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $31.8 million.

  • Organogenesis Holdings' Net Cash Flow fell 310.45% to -$9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.6 million, marking a year-over-year decrease of 683.64%. This contributed to the annual value of $31.8 million for FY2024, which is 2935.59% up from last year.
  • Latest data reveals that Organogenesis Holdings reported Net Cash Flow of $31.8 million as of FY2024, which was up 2,935.59% from $1.0 million recorded in FY2023.
  • Over the past 5 years, Organogenesis Holdings' Net Cash Flow peaked at $31.8 million during FY2024, and registered a low of -$11.2 million during FY2022.
  • For the 3-year period, Organogenesis Holdings' Net Cash Flow averaged around $7.2 million, with its median value being $1.0 million (2023).
  • As far as peak fluctuations go, Organogenesis Holdings' Net Cash Flow slumped by 137.81% in 2022, and later skyrocketed by 2,935.59% in 2024.
  • Yearly analysis of 5 years shows Organogenesis Holdings' Net Cash Flow stood at $24.4 million in 2020, then grew by 21.63% to $29.7 million in 2021, then slumped by 137.81% to -$11.2 million in 2022, then skyrocketed by 109.33% to $1.0 million in 2023, then surged by 2,935.59% to $31.8 million in 2024.